Development of a quality assessment tool for pharmacy and therapeutics committees and subsequent pilot testing.

Health Care Economics and Organizations MEDICATION SYSTEMS, HOSPITAL PHARMACY SERVICE, HOSPITAL Practice Guideline Quality Assurance, Health Care Quality of Health Care Safety

Journal

European journal of hospital pharmacy : science and practice
ISSN: 2047-9956
Titre abrégé: Eur J Hosp Pharm
Pays: England
ID NLM: 101578294

Informations de publication

Date de publication:
22 Feb 2024
Historique:
received: 02 05 2022
accepted: 26 09 2022
medline: 26 2 2024
pubmed: 15 10 2022
entrez: 14 10 2022
Statut: epublish

Résumé

Pharmacy and therapeutics committees (PTCs) are multidisciplinary hospital teams responsible for rational medication use. We aimed at developing and piloting an assessment tool for their operating quality.We conducted a scoping literature review in PubMed and Embase to identify potential assessment items. Their relevance was systematically rated and consolidated into the final tool.60 relevant items were included, grouped into eight focus topics: the committee's institutional integration, member characteristics, performance indicators, meeting structure, formulary decision-making and characteristics, strategies to guide medication use and medication use evaluations.In combination with a SWOT (strengths, weaknesses, opportunities and threats) analysis, the tool helped the identification of improvement opportunities for a pilot hospital: adapting the committee's structure, improving the formulary decision-making, implementing strategies to guide formulary medication use and strengthening the committee's recognition within the institution.The tool successfully identified improvement opportunities for a PTC and could therefore be interesting for other hospitals.

Identifiants

pubmed: 36241377
pii: ejhpharm-2022-003365
doi: 10.1136/ejhpharm-2022-003365
pmc: PMC10895181
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

171-174

Informations de copyright

© European Association of Hospital Pharmacists 2024. Re-use permitted under CC BY-NC. No commercial re-use. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Basic Clin Pharmacol Toxicol. 2014 Sep;115(3):268-76
pubmed: 24528496
Eur J Clin Pharmacol. 2013 May;69 Suppl 1:79-87
pubmed: 23640192
Hosp Pharm. 2013 Jul;48(7):568-73
pubmed: 24421522
Br J Clin Pharmacol. 1998 Apr;45(4):393-8
pubmed: 9578188
Pharm World Sci. 1999 Apr;21(2):74-9
pubmed: 10380234
Eur J Clin Pharmacol. 2006 Jan;62(1):57-63
pubmed: 16372173
Am J Health Syst Pharm. 2008 Jul 1;65(13):1272-83
pubmed: 18589893
Am J Health Syst Pharm. 2015 Mar 1;72(5):408-13
pubmed: 25694416
Am J Health Syst Pharm. 2017 Sep 1;74(17):1336-1352
pubmed: 28743758
Expert Rev Clin Pharmacol. 2018 Dec;11(12):1255-1262
pubmed: 30451035

Auteurs

Nicole Schönenberger (N)

Department of General Internal Medicine, Clinical Pharmacology and Toxicology, University Hospital of Bern - Inselspital Bern, Bern, Switzerland.

Carla Meyer-Massetti (C)

Department of General Internal Medicine, Clinical Pharmacology and Toxicology, University Hospital of Bern - Inselspital Bern, Bern, Switzerland carla.meyer-massetti@extern.insel.ch.
Institute for Primary Healthcare BIHAM, University of Bern, Bern, Switzerland.

Silvina Bravo (S)

University Hospital of Zürich, Zürich, Switzerland.

Articles similaires

Aerosols Humans Decontamination Air Microbiology Masks
COVID-19 Humans Deep Learning Cost-Benefit Analysis Spain
Enterococcus faecium Italy Anti-Bacterial Agents Humans Gram-Positive Bacterial Infections

Dynamic location model for designated COVID-19 hospitals in China.

Wang Fei, Yuan Linghong, Zhang Weigang et al.
1.00
COVID-19 Humans China SARS-CoV-2 Algorithms

Classifications MeSH